<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1688-1249</journal-id>
<journal-title><![CDATA[Archivos de Pediatría del Uruguay]]></journal-title>
<abbrev-journal-title><![CDATA[Arch. Pediatr. Urug.]]></abbrev-journal-title>
<issn>1688-1249</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Uruguaya de Pediatría]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1688-12492021000101206</article-id>
<article-id pub-id-type="doi">10.31134/ap.92.1.13</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Vacuna HPV: ¿la recomiendan los pediatras de diferentes prestadores de salud en Montevideo?]]></article-title>
<article-title xml:lang="en"><![CDATA[HPV vaccine: is it recommended by the pediatricians of the different health service providers in Montevideo?]]></article-title>
<article-title xml:lang="pt"><![CDATA[Vacina HPV: é recomendada pelos pediatras dos diferentes prestadores de serviços de saúde de Montevidéu?]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[González]]></surname>
<given-names><![CDATA[Virginia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Holcberg]]></surname>
<given-names><![CDATA[Mónica]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Díaz]]></surname>
<given-names><![CDATA[Antonella]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Duarte]]></surname>
<given-names><![CDATA[Banesa]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Deragón]]></surname>
<given-names><![CDATA[Juan]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Duarte]]></surname>
<given-names><![CDATA[Julieta]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rosa]]></surname>
<given-names><![CDATA[Valentina Da]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Fraga]]></surname>
<given-names><![CDATA[Victoria]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,UDELAR Facultad de Medicina Clínica Pediátrica B]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Uruguay</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,UDELAR Facultad de Medicina Clínica Pediátrica A]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Uruguay</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,UDELAR Ciclo Metodología Científica II ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Uruguay</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2021</year>
</pub-date>
<volume>92</volume>
<numero>1</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_arttext&amp;pid=S1688-12492021000101206&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_abstract&amp;pid=S1688-12492021000101206&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_pdf&amp;pid=S1688-12492021000101206&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen:  Introducción:  la infección por el virus de papiloma humano (HPV) es la infección de transmisión sexual más frecuente en el mundo, vinculándose a lesiones premalignas y cáncer de cuello uterino (CCU). En Uruguay es el tercer tipo de cáncer en frecuencia y la cuarta causa de mortalidad por cáncer en mujeres. Existen vacunas contra HPV seguras y eficaces. En Uruguay en 2013 se comenzó a administrar de forma gratuita la vacuna tetravalente (serotipos16,18,11y 6) para todas las adolescentes de 11 años y desde 2019 también a los varones de la misma franja etaria. La cobertura de la vacuna aún es baja.  Objetivo:  conocer la actitud de algunos pediatras de Montevideo frente a la indicación de la vacuna contra HPV.  Materiales y métodos:  se realizó un estudio descriptivo, observacional, transversal mediante encuesta anónima y autogestionada a pediatras de diferentes prestadores de salud: Casmu, Hospital Militar, Hospital Británico y Casa de Galicia, en agosto-setiembre de 2018.  Resultados:  total: 67 pediatras encuestados: 66 recomiendan la vacuna, 58 consideran que tiene información necesaria sobre la vacuna, 64 conocen las indicaciones y contraindicaciones, a 63 les gustaría contar con información oficial por parte del Ministerio de Salud Pública, 63 consideran que los pacientes no tienen información adecuada, 21 necesitan entre 15 -30 min para dar información y 65 piensa que puede influir en la postura de los padres frente a la vacuna.  Conclusiones:  los pediatras encuestados recomiendan la vacuna contra el HPV en sus consultas. La confianza en el médico y la necesidad de información son dos variables fundamentales sobre las que tenemos que seguir trabajando. Se necesita profundizar en éstos y otros aspectos que influyen negativamente en la decisión de los adolescentes y sus tutores, determinando una baja cobertura de vacunación.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Summary:  Introduction:  the human papillomavirus (HPV) infection is the most frequent sexually transmitted disease globally, associated with pre malignant lesions and uterine cervical cancer. It is the third most frequent type of cancer in Uruguay and the fourth cause of death in women with cancer. There are safe and effective HPV vaccines. In 2013, Uruguay started administering the quadrivalent vaccine (serotypes 16, 18, 11 and 6), for free to all 11-year-old adolescent girls, and in 2019 to all adolescent boys of the same age. The HPV vaccine coverage is still low.  Objective:  to learn about the position of some pediatricians from Montevideo, Uruguay, regarding the HPV vaccine.  Methodology:  cross-sectional observational descriptive study, carried out through anonymous, self-administered surveys to some pediatricians from different health providers: Casmu, Armed Forces Hospital, British Hospital and Casa de Galicia, from August to September 2018.  Results:  total: 67 surveyed pediatricians, 66 recommend the vaccine, 58 believe that they have all the necessary information about the vaccine, 64 understand the indications and contraindications, 63 would like to have official information from the Ministry of Public Health, 63 think that patients do not have adequate information about the vaccine, 21 consider they need between 15 and 30 minutes to give information to patients about the vaccine and 65 think they can influence the parents&#8217; opinions regarding the use of the vaccine.  Conclusions:  the surveyed pediatricians recommend the HPV vaccine. We need to continue to research the issues of trust in doctors and the need for additional information, as well as other aspects, because they are a negative influence when adolescents and their tutors need to make decisions regarding the use of the vaccine, which results into low adherence.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo:  Introdução:  a infecção pelo papilomavírus humano (HPV) é a infecção sexualmente transmissível mais comum no mundo, e está associada a lesões pré-malignas e câncer cervical (CCU). No Uruguai, é o terceiro tipo de câncer mais frequente e a quarta causa de mortalidade por câncer em mulheres. Existem vacinas contra o HPV seguras e eficazes. No Uruguai, em 2013, a vacina quadrivalente (sorotipos 16,18,11 e 6) começou a ser administrada gratuitamente a todas as adolescentes de 11 anos e, a partir de 2019, também a homens adolescentes da mesma faixa etária. A cobertura vacinal ainda é baixa.  Objetivo:  conhecer a opinião de alguns pediatras de Montevidéu quanto à indicação da vacina contra o HPV.  Materiais e métodos:  realizou-se um estudo descritivo, observacional e transversal por meio de um inquérito anônimo e autogerido com pediatras de diferentes prestadores de saúde: Casmu, Hospital Militar, Hospital Britânico e Casa de Galicia, de agosto a setembro de 2018.  Resultados:  total: 67 pediatras pesquisados: 66 recomendam a vacina, 58 consideram que possuem a informação necessária sobre a vacina, 64 conhecem as indicações e contraindicações, 63 gostariam de ter informação oficial do Ministério da Saúde Pública, 63 consideram que o os pacientes não possuem informação adequada, 21 acham que precisam de 15 a 30 minutos para fornecer informação aos pacientes e 65 acham que poderiam influenciar a posição dos pais em relação à vacina.  Conclusões:  os pediatras pesquisados recomendam a vacina contra o HPV em suas consultas. A confiança no médico e a necessidade de informação são duas variáveis fundamentais nas quais ainda devemos continuar trabalhando. É necessário aprofundar esses e outros aspectos que influenciam negativamente na decisão dos adolescentes e seus responsáveis, determinando uma baixa cobertura vacinal.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Papillomaviridae]]></kwd>
<kwd lng="es"><![CDATA[Vacunas]]></kwd>
<kwd lng="es"><![CDATA[Cobertura de vacunación]]></kwd>
<kwd lng="es"><![CDATA[Encuestas y cuestionarios]]></kwd>
<kwd lng="es"><![CDATA[Pediatras]]></kwd>
<kwd lng="en"><![CDATA[Papillomaviridae]]></kwd>
<kwd lng="en"><![CDATA[Vaccines]]></kwd>
<kwd lng="en"><![CDATA[Vaccination coverage]]></kwd>
<kwd lng="en"><![CDATA[Surveys and questionnaires]]></kwd>
<kwd lng="en"><![CDATA[Pediatricians]]></kwd>
<kwd lng="pt"><![CDATA[Papillomaviridae]]></kwd>
<kwd lng="pt"><![CDATA[Vacinas]]></kwd>
<kwd lng="pt"><![CDATA[Cobertura vacinal]]></kwd>
<kwd lng="pt"><![CDATA[Inquéritos e questionários]]></kwd>
<kwd lng="pt"><![CDATA[Pediatras]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Berois]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[De Cremoux]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Mazal]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Sica]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Cedeira]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Caserta]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalence and distribution of high-risk human papillomavirus genotypes in invasive carcinoma of the uterine cervix in Uruguay]]></article-title>
<source><![CDATA[Int J Gynecol Cancer]]></source>
<year>2013</year>
<volume>23</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>527-32</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="book">
<collab>Ministerio de Salud Pública</collab>
<source><![CDATA[Guía de práctica clínica de tamizaje de cáncer de cuello de útero]]></source>
<year>2010</year>
<publisher-loc><![CDATA[Montevideo ]]></publisher-loc>
<publisher-name><![CDATA[MSP]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Monnier]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Dalstein]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Riethmuller]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Lalaoui]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Mougin]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Prétet]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dynamics of HPV16 DNA load reflect the natural history of cervical HPV-associated lesions]]></article-title>
<source><![CDATA[J Clin Virol]]></source>
<year>2006</year>
<volume>35</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>270-7</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="book">
<collab>Comisión Honoraria de Lucha contra el Cáncer</collab>
<source><![CDATA[Programa de Prevención del Cáncer de Cuello Uterino "Dr. Enrique Pouey." Resumen: 1994-2012]]></source>
<year>2015</year>
<publisher-loc><![CDATA[Montevideo ]]></publisher-loc>
<publisher-name><![CDATA[CHLCC]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="book">
<collab>Ministerio de Salud Pública</collab>
<collab>Comisión Honoraria de Lucha Contra el Cáncer</collab>
<source><![CDATA[Plan nacional de prevención integral de cáncer de cuello uterino. 2012-2015]]></source>
<year>2016</year>
<publisher-loc><![CDATA[Montevideo ]]></publisher-loc>
<publisher-name><![CDATA[MSP]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nozar]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Briozzo]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cáncer de cuello uterino en Uruguay: controversias en la prevención]]></article-title>
<source><![CDATA[Rev Méd Urug]]></source>
<year>2017</year>
<volume>33</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>64-70</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="book">
<collab>Organización Panamericana de la Salud</collab>
<source><![CDATA[Control integral del cáncer cervicouterino: guía de prácticas esenciales.]]></source>
<year>2016</year>
<publisher-loc><![CDATA[Washington, DC ]]></publisher-loc>
<publisher-name><![CDATA[OPS]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arbyn]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Xu]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Simoens]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Martin]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Vacunación profiláctica contra el virus del papiloma humano para prevenir el cáncer de cuello uterino y sus precursores]]></article-title>
<source><![CDATA[Cochrane Database Syst Rev]]></source>
<year>2018</year>
<volume>5</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>CD009069</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bruni]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Serrano]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Bosch]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Castellsagué]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Vacuna frente al virus del papiloma humano eficacia y seguridad]]></article-title>
<source><![CDATA[Enferm Infecc Microbiol Clin]]></source>
<year>2015</year>
<volume>33</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>342-54</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Giuliano]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Palefsky]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Goldstone]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Moreira]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Penny]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Aranda]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2011</year>
<volume>364</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>401-11</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Harder]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Wichmann]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Klug]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Efficacy, effectiveness and safety of vaccination against human papillomavirus in males a systematic review]]></article-title>
<collab>van der M.Wiese M</collab>
<source><![CDATA[BMC Med]]></source>
<year>2018</year>
<volume>16</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>110</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Green]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[HPV vaccine to be offered to boys in England]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2018</year>
<volume>392</volume>
<numero>10145</numero>
<issue>10145</issue>
<page-range>374</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="book">
<collab>Ministerio de Salud Pública</collab>
<source><![CDATA[Vacuna contra el Virus del Papiloma Humano. Información para su ofrecimiento en el marco del Plan Nacional de Prevención del Cáncer de Cuello Uterino]]></source>
<year>2015</year>
<publisher-loc><![CDATA[Montevideo ]]></publisher-loc>
<publisher-name><![CDATA[MSP]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="">
<collab>Ministerio de Salud Pública</collab>
<source><![CDATA[MSP aprobó reducción a dos dosis de vacuna HPV]]></source>
<year>2017</year>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="">
<collab>Sociedad Uruguaya de Pediatría</collab>
<collab>Sociedades Científicas Anexas de la Sociedad de Ginecotología del Uruguay</collab>
<collab>Sociedad de Infectología Clínica del Uruguay</collab>
<source><![CDATA[Comunicados sobre la vacunación contra el HPV]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Viroga]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Speranza]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Seguridad de la vacuna VPH: ¿qué sabemos y qué hay de nuevo?]]></article-title>
<source><![CDATA[Bol Farmacol]]></source>
<year>2016</year>
<volume>7</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1-6</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="book">
<collab>Comisión Honoraria para la Lucha Antituberculosa y Enfermedades Prevalentes</collab>
<source><![CDATA[Uruguay: coberturas de vacunación]]></source>
<year>2017</year>
<publisher-loc><![CDATA[Montevideo ]]></publisher-loc>
<publisher-name><![CDATA[CHLA-EP]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cardozo]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Antivacunas: la nueva caza de brujas]]></article-title>
<source><![CDATA[La Diaria]]></source>
<year>2018</year>
<publisher-loc><![CDATA[Montevideo ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Sociedad de Pediatría apoya vacunación contra el HPV en las escuelas]]></article-title>
<source><![CDATA[El Observador]]></source>
<year>2018</year>
<publisher-loc><![CDATA[Montevideo ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[González]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Vacuna contra HPV en las escuelas reaviva polémica]]></article-title>
<source><![CDATA[El País]]></source>
<year>2018</year>
<publisher-loc><![CDATA[Montevideo ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<collab>Redacción 180</collab>
<article-title xml:lang=""><![CDATA[Más de la mitad de los padres autorizó que sus hijos sean vacunados en las escuelas]]></article-title>
<source><![CDATA[Canal 180]]></source>
<year>2018</year>
<publisher-loc><![CDATA[Montevideo ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="book">
<collab>Ministerio de Salud Pública</collab>
<source><![CDATA[Comunicado de Prensa: vacunación contra HPV en varones]]></source>
<year>2019</year>
<publisher-loc><![CDATA[Montevideo ]]></publisher-loc>
<publisher-name><![CDATA[MSP]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alonso]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<source><![CDATA[Valoración mediante una encuesta de la negativa a la vacunación frente al virus del papiloma humano: estudio de los motivos para no vacunar]]></source>
<year>2017</year>
<publisher-loc><![CDATA[Castelló de la Plana, ES ]]></publisher-loc>
<publisher-name><![CDATA[Universitat Jaume I-Unitat, Predepartamental de Medicina]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Nueva vacunación en escuelas con énfasis en dosis contra VPH]]></article-title>
<source><![CDATA[Diario Cambio]]></source>
<year>2018</year>
<publisher-loc><![CDATA[Salto ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Godlee]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Smith]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Marcovitch]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Wakefield's article linking MMR vaccine and autism was fraudulent]]></article-title>
<source><![CDATA[BMJ]]></source>
<year>2011</year>
<volume>342</volume>
<page-range>c7452</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="book">
<collab>Ministerio de Salud Pública</collab>
<source><![CDATA[Vigilancia de efecto adverso supuestamente atribuibles a la vacunación e inmunización (ESAVI)]]></source>
<year>2020</year>
<publisher-loc><![CDATA[Montevideo ]]></publisher-loc>
<publisher-name><![CDATA[MSP]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<collab>World Health Organization</collab>
<article-title xml:lang=""><![CDATA[Safety update of HPV vaccines]]></article-title>
<source><![CDATA[Wkly Epidemiol Rec]]></source>
<year>2017</year>
<volume>92</volume>
<numero>28</numero>
<issue>28</issue>
<page-range>398-402</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pérez]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Brasó]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Medina]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Conocimiento de los médicos especialistas o en formación acerca de vacunas no sistemáticas en Uruguay]]></article-title>
<source><![CDATA[Rev Méd Urug]]></source>
<year>2017</year>
<volume>33</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>34-46</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Abi]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Khair]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Dagher]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Saad]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Cherfan]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Kaafarani]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factors associated with Human Papilloma Virus (HPV) vaccine recommendation by physicians in Lebanon, a cross-sectional study]]></article-title>
<source><![CDATA[Vaccine]]></source>
<year>2018</year>
<volume>36</volume>
<numero>49</numero>
<issue>49</issue>
<page-range>7562-7</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
